Sele was upregulated in ECs from eight disease models including CCM, EAE, stroke, TBI, epilepsy, AOD, diabetic nephropathy, Alport syndrome, and NASH, highlighting the broad role of Sele in multiple disease progressions (Silva et al., 2017). This evidence concerns the gene SELE and diabetic kidney disease.